(Q33901618)

29 July 2017

1 reference

title

Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature (English)

1 reference

endometrial adenocarcinoma

29 July 2017

1 reference

1 reference

1 reference

Kounelis S

1

1 reference

29 July 2017

Kapranos N

2

1 reference

29 July 2017

Kouri E

3

1 reference

29 July 2017

Coppola D

4

1 reference

29 July 2017

Papadaki H

5

1 reference

29 July 2017

Jones MW

6

1 reference

29 July 2017

publication date

1 April 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

13

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

379-388

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3880062

29 July 2017

exact match

0 references

cites work

Endometrial cancer: biochemical and clinical correlates

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Uterine papillary serous carcinoma evolves via a p53-driven pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

BanII and ScaI RFLPs at the human p53 gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

bcl-2 protein in non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Immunohistochemical Evaluation of Estrogen and Progesterone Receptor Content in 183 Patients with Endometrial Carcinoma: Part I: Clinical and Histologic Correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlations with stage and other clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

p53 expression in neoplasms of the uterine corpus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

p53 gene mutations in human endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Bcl-2 and the regulation of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

bcl-2: role in epithelial differentiation and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Immunohistochemical analysis of p53 in gynecologic tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Endometrial carcinoma in situ in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

bcl-2 expression in endometrial hyperplasia and carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Expression of Bax, a pro-apoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

The relationship of histologic and histochemical parameters to progesterone receptor status in endometrial adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Prognostic significance of hormone receptors in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880062

7 January 2021

10.1038/MODPATHOL.3880062

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1020167158

0 references

1 reference